
American Transplant Congress 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Transplant Congress 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
ATC 2026 - American Transplant Congress
Event type: Transplant medicine, organ transplantation, surgery, clinical research, hospital systems, pharma/biotech, medical devices, patient care, donor advocacy
Estimated attendance: Typically a major international medical congress with several thousand attendees, including physicians, surgeons, researchers, coordinators, hospital leaders, industry partners, and transplant care professionals.
Audience reach: Global with a strong North American concentration
1️⃣ Who attends: Buyers / attendees
ATC 2026 is a highly specialized medical and scientific congress built around the transplant ecosystem. This is not a broad consumer healthcare event; it is a professional decision-maker environment where the strongest buyer opportunities come from hospitals, transplant centers, academic medical institutions, life sciences organizations, medical device companies, diagnostic firms, and healthcare service providers.
The attendee base usually includes transplant surgeons, transplant hepatologists, nephrologists, cardiologists, pulmonologists, anesthesiologists, immunologists, pathologists, critical care specialists, transplant coordinators, procurement teams, clinical trial teams, research scientists, hospital administrators, and healthcare procurement leaders.
In addition to clinicians, this event attracts pharma and biotech professionals focused on immunosuppression, rejection management, organ preservation, cell therapy, biomarker research, donor matching, surgical tools, imaging, and post-transplant care. For attendee-list monetization, the most valuable contacts are the people involved in treatment decisions, purchasing decisions, partnerships, clinical operations, research, and training.
2️⃣ Where the show is happening + attendee geographic origin
Location: ATC 2026 is expected to be held in a major U.S. convention destination. Final venue details should be confirmed from the official event website once available.
Geographic origin of attendees: This congress usually draws a strong U.S. national audience with significant international participation from Europe, Asia-Pacific, Latin America, the Middle East, and Canada. Because transplant medicine is a global field, the attendee pool tends to include worldwide specialists, especially from major academic hospitals, transplant centers, and research universities.
Best geographic targeting:
- United States nationwide, especially major transplant hubs
- Canada, United Kingdom, Germany, France, Spain, Italy, Netherlands, Switzerland
- India, Japan, South Korea, Singapore, Australia, Brazil, and the Gulf region
- Large academic and hospital networks with transplant programs
3️⃣ Audience reach: Local / National / Global
Reach type: Global with national strength in the U.S.
ATC is not a local or regional event. It is an international scientific congress that brings together transplant professionals from across the world. The strongest commercial opportunity is in the U.S. market, but the reach and influence are clearly global because the topics affect worldwide clinical practice, research, device adoption, and transplant therapy development.
For buyer-list sales, this means the event is highly valuable for brands that want access to decision-makers in hospitals, transplant programs, medical research, and regulated healthcare procurement.
4️⃣ Sample buyer company names + websites
Below is a sample buyer-target table with organizations that are a strong fit for transplant medicine, surgical care, organ preservation, diagnostics, immunology, hospital systems, biopharma, and medical technology. These are buyer-style targets, not just random attendees.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Fresenius Medical Care | freseniusmedicalcare.com | Director of Transplant Strategy / Clinical Partnerships Manager | Strong relevance to kidney care, nephrology, and transplant-related clinical workflows. |
| 2 | Medtronic | medtronic.com | Senior Product Manager, Surgical Solutions / Clinical Marketing Manager | Major medical technology company with strong hospital and surgical ecosystem presence. |
| 3 | BD | bd.com | Hospital Solutions Director / Clinical Affairs Manager | Relevant for clinical devices, diagnostics, and hospital-based procedure support. |
| 4 | AbbVie | abbvie.com | Medical Science Liaison / Immunology Marketing Director | Highly relevant to immune modulation and post-transplant care discussions. |
| 5 | Novartis | novartis.com | Transplant Portfolio Manager / Medical Affairs Manager | Important transplant and immunology fit with strong clinical influence. |
| 6 | Gilead Sciences | gilead.com | Medical Affairs Director / Clinical Research Lead | Relevant to virology, immunology, and hospital-based specialty care. |
| 7 | Thermo Fisher Scientific | thermofisher.com | Life Sciences Sales Director / Research Partnerships Manager | Very strong fit for diagnostics, research tools, biomarkers, and lab workflows. |
| 8 | Illumina | illumina.com | Clinical Genomics Manager / Hospital Accounts Director | Relevant for genomic screening, donor matching, and precision medicine. |
| 9 | Siemens Healthineers | siemens-healthineers.com | Imaging Solutions Director / Strategic Accounts Manager | Fits transplant diagnostics, imaging, hospital systems, and procedure support. |
| 10 | Philips | philips.com | Clinical Partnerships Manager / Hospital Solutions Lead | Strong hospital and care delivery fit across monitoring and clinical technology. |
| 11 | OrganOx | organox.com | Business Development Director / Clinical Adoption Manager | Directly aligned with organ preservation and transplant innovation. |
| 12 | VitalTech | vitaltech.com | Healthcare Partnerships Manager / Product Marketing Lead | Good fit for remote monitoring and patient engagement in transplant follow-up. |
| 13 | United Therapeutics | unither.com | Medical Affairs Director / Clinical Program Manager | Strong transplant-related therapeutic and clinical research alignment. |
| 14 | Fujifilm Healthcare | fujifilm.com | Healthcare Sales Director / Clinical Applications Manager | Relevant to imaging, diagnostics, and hospital workflow solutions. |
| 15 | Johnson & Johnson MedTech | jnj.com | Surgical Innovation Director / Strategic Accounts Manager | Excellent fit for surgery, hospital procurement, and clinical education. |
| 16 | Roche Diagnostics | roche.com | Diagnostics Product Manager / Market Development Director | Very strong fit for laboratory testing, biomarker discovery, and clinical diagnostics. |
| 17 | Mass General Brigham | massgeneralbrigham.org | Transplant Program Director / Procurement Manager | Major academic health system with transplant operations and purchasing influence. |
| 18 | Mayo Clinic | mayoclinic.org | Director of Transplant Services / Research Administration Manager | High-value academic medical buyer with clinical research and procurement needs. |
| 19 | Cleveland Clinic | clevelandclinic.org | Transplant Center Administrator / Clinical Research Manager | Leading transplant and specialty care institution with strong buying authority. |
| 20 | Houston Methodist | houstonmethodist.org | Hospital Purchasing Director / Transplant Operations Manager | Large hospital system with specialty care, surgical services, and program investment. |
Top 5 best sample accounts to send first: Mayo Clinic, Cleveland Clinic, Mass General Brigham, Novartis, Thermo Fisher Scientific. These represent a balanced mix of hospital buyers, academic transplant programs, and life sciences companies with strong relevance to transplant medicine.
5️⃣ Job profiles, industries & event type
The right attendee list for this event should focus on clinical, scientific, operational, and procurement-related decision-makers. Since this is a highly specialized medical congress, the value is not only in doctors but also in research leaders, hospital administrators, and industry business contacts.
Best job profiles to target:
- Transplant Surgeon
- Transplant Physician / Hepatologist / Nephrologist / Cardiologist / Pulmonologist
- Medical Director, Transplant Program
- Director of Transplant Services
- Clinical Research Director
- Research Scientist, Immunology / Regenerative Medicine
- Hospital Procurement Manager
- Clinical Affairs Manager
- Medical Science Liaison
- Product Manager, Life Sciences / Diagnostics
- Director of Clinical Partnerships
- Transplant Coordinator
- Organ Procurement Organization Leader
- Healthcare Strategy Director
- Innovation and Surgical Technology Manager
Best industries to use:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Research
- Medical Practice
- Biopharmaceutical-related organizations under life sciences keywords
- Information Services for healthcare analytics firms
- Higher Education for medical schools and research institutions
- Government Administration for public health and transplant policy bodies
Event type: This is a scientific and clinical congress with a strong commercial layer. The commercial layer comes from hospital systems, device makers, diagnostics firms, pharmaceutical brands, transplant support organizations, and clinical research vendors.
6️⃣ Estimated attendance / expected footfall
ATC is generally considered a high-quality medical congress with significant professional attendance. While exact attendance for 2026 should be confirmed from the official event page or organizer release, the event usually draws several thousand participants and a strong mix of clinicians, researchers, industry staff, and institution leaders.
Estimated total footfall: Several thousand attendees, often in the range of a large international specialty congress.
What matters most here is not raw footfall alone, but the concentration of high-value buyers and influencers. This event is especially strong in account quality because attendees are tied to treatment pathways, hospital systems, research budgets, and product evaluation.
7️⃣ Key focus areas & buyer engagement
Key focus areas:
- Organ transplantation science and clinical best practices
- Immunosuppression and rejection management
- Donor matching and allocation
- Organ preservation and perfusion technologies
- Transplant surgery techniques
- Post-transplant monitoring and patient management
- Biomarkers, diagnostics, and lab testing
- Regenerative medicine, cell therapy, and novel therapies
- Hospital workflow and transplant program optimization
- Research collaboration and clinical trial advancement
Buyer engagement angle:
The best engagement strategy is to position the attendee list around transplant decision-makers, not just general healthcare contacts. Strong messaging would focus on transplant surgeons, nephrology and hepatology leaders, transplant program administrators, hospital procurement teams, research directors, and medtech/pharma partners involved in transplant innovation.
If your client sells a device, diagnostic solution, clinical software, patient management platform, surgical product, or life sciences offering, this event can be highly valuable. However, the buyer fit depends heavily on what your client sells.
8️⃣ Client product fit note
Please share your client’s website before finalizing the best buyer list. The most relevant contacts change significantly based on product category.
Examples:
- If the client sells medical devices, target transplant surgeons, OR leaders, hospital procurement, and medtech companies.
- If the client sells diagnostics or lab tools, target pathology, lab directors, immunology teams, and research organizations.
- If the client sells pharma or biologics, target medical affairs, transplant physicians, immunology leaders, and clinical trial teams.
- If the client sells software or analytics, target transplant coordinators, hospital operations, clinical research, and health IT teams.
- If the client sells services, target hospital systems, transplant program administrators, and academic medical centers.
Once you share the client website, I can refine the buyer shortlist and prioritize the best target accounts based on exact product-market fit.
9️⃣ Industry recommendation based on the industry list
For this event, the strongest industry filters from your list are:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Medical Practice
- Research
- Higher Education
- Information Services
- Government Administration
- Health, Wellness & Fitness only if the client is on patient engagement or care support side
If you want stronger buyer precision, add keywords around transplant, surgery, organ preservation, immunology, nephrology, hepatology, cardiology, critical care, diagnostics, and clinical research.
Final recommendation
ATC 2026 is a strong, high-value event for attendee-list sales because it concentrates clinical specialists, hospital decision-makers, researchers, and healthcare industry buyers in one place. It is not a broad mass-market show, but that is actually a strength for premium B2B targeting.
Best buyer segments to collect:
- Transplant surgeons and physicians
- Hospital transplant program leaders
- Clinical research and medical affairs teams
- Procurement and purchasing teams in hospitals
- Pharma, biotech, diagnostics, and medtech partners
- Academic medical center leadership
Quality rating for B2B attendee-list sales: 9/10
This event is highly targeted, medically specialized, globally respected, and rich in decision-makers. The only caution is that the attendee list must be segmented carefully by role and buying intent to maximize value.
Next step: Please share your client website, and I will review it to identify the best buyer accounts, best job titles, and the most suitable industries for ATC 2026.
Data sheet
| Event Name | American Transplant Congress 2026 |
| Event Date | June 20–24, 2026 |
| Event Status | Upcoming |
| Venue | Thomas Michael Menino Convention and Exhibition Center |
| City | Boston |
| State / Region | Massachusetts |
| Country | United States |
| Organizer | American Society of Transplantation (AST) and American Society of Transplant Surgeons (ASTS) – historical event organizers for the American Transplant Congress event series; 2026 edition should be verified on the official event website when the page is live. |
| Official Event Website | atcmeeting.org |
| Event Type | Medical congress / scientific conference / clinical education and industry engagement event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global with strong North American concentration |
| Estimated Attendance / Expected Footfall | Several thousand attendees is likely based on the scale and standing of prior American Transplant Congress editions. Attendance figure not publicly confirmed by the organizer for 2026 at the time of this report. |
| Attendance Data Reliability | Estimated / historical event-series evidence; current-year public attendance figure not confirmed |
| Main Purpose of Event | To convene the transplant medicine ecosystem for clinical education, scientific presentation, surgical and care-delivery best practices, research collaboration, product awareness, institutional networking, and commercial engagement across transplant-related therapies, diagnostics, devices, services, and hospital operations. |
American Transplant Congress (ATC) is a specialized medical and scientific congress focused on organ transplantation, transplant surgery, immunology, post-transplant care, donor issues, clinical outcomes, and translational research. The event typically brings together transplant physicians, surgeons, researchers, nurses, coordinators, academic centers, hospital systems, industry partners, and patient-care stakeholders in one concentrated professional environment.
For suppliers, ATC matters because it is a high-value decision-maker setting rather than a broad consumer health expo. The strongest commercial relevance is in transplant-center operations, clinical technology, diagnostics, immunosuppression and specialty therapeutics, organ preservation, lab and research solutions, data and workflow systems, and hospital procurement. It is especially useful for lead generation into transplant programs, academic medicine, health systems, and life sciences organizations that influence adoption, trials, protocols, and long-cycle purchasing decisions.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Transplant surgeons and surgical leadership | Academic medical centers, transplant hospitals, surgical programs | High clinical influence over devices, preservation solutions, OR tools, protocols, and vendor evaluation | Critical for high-value clinical adoption and physician-led purchasing pathways |
| Transplant physicians and specialty clinicians | Kidney, liver, heart, lung and multi-organ transplant programs | Protocol selection, therapeutic preference, diagnostic use, trial participation | Essential for therapies, diagnostics, care pathways, and post-transplant monitoring solutions |
| Transplant coordinators and nursing leadership | Hospital transplant programs, integrated delivery networks | Workflow influence, patient management, implementation feedback, vendor usability assessment | Strong fit for workflow software, patient engagement, monitoring, and support services |
| Hospital procurement and supply chain teams | Hospital systems, teaching hospitals, transplant centers | Contracting, sourcing, vendor onboarding, purchasing approval | Direct buyer segment for capital, consumables, software, lab services, and outsourced support |
| Clinical research teams and principal investigators | Universities, academic hospitals, research institutes | Trial design, protocol review, sample and data platform selection | Important for biomarkers, CRO support, lab services, data capture, and translational technologies |
| Pharma and biotech medical/scientific teams | Transplant therapeutics, immunology, cell therapy, specialty pharma firms | Partnership, evidence generation, investigator engagement, product strategy | Relevant for co-development, trial support, market access, and disease-area collaboration |
| Medical device and diagnostics leaders | Device manufacturers, preservation technology firms, diagnostics companies | Commercial and clinical evaluation, channel partnerships, solution sourcing | Good fit for complementary technologies and alliance-based selling |
| Hospital executives and service-line administrators | Health systems, academic medical centers | Budget oversight, program expansion, vendor approvals, operational strategy | High-value targets for enterprise healthcare solutions and strategic partnerships |
| Organ donation, procurement and advocacy stakeholders | Organ procurement organizations, nonprofits, donor advocacy groups | Program operations, awareness, logistics, coordination influence | Relevant for donor systems, communication, logistics, education, and support services |
| Industry consultants and solution partners | Healthcare consulting, reimbursement, clinical operations, digital health vendors | Influence selection, implementation, and strategic buying decisions | Useful multiplier segment for channel relationships and account access |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Boston | Local clinicians, academic medicine, hospital systems, biotech participants | High | Boston is a major U.S. medical, teaching hospital, and life sciences hub with strong relevance to transplantation and immunology. |
| Massachusetts / New England | Regional hospital systems, universities, biotech firms, healthcare suppliers | High | Strong pull from Boston, Cambridge, Worcester, Providence, Hartford, and nearby academic centers. |
| Northeast U.S. | Major transplant centers, integrated delivery networks, pharma and device firms | High | Likely draw from New York, Pennsylvania, New Jersey, Maryland, and Washington-area institutions. |
| United States | National physician, hospital, transplant-program, and industry attendance | Very High | ATC is a nationally recognized transplant congress with broad participation across U.S. transplant medicine and research. |
| Canada | Academic hospitals, specialists, collaborative researchers | Medium | Likely cross-border participation due to the congress’s scientific profile and North American relevance. |
| International | Researchers, clinical faculty, specialty industry partners, select transplant centers | Medium to High | Global attendance is likely, especially among academic and life sciences participants, but North America remains the core buyer base. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event serves an international transplant medicine and research audience, with participation likely extending beyond the U.S. through academic, hospital, and industry channels. |
| National | Strong secondary reach | The highest concentration of buyer-side opportunity is likely within U.S. transplant centers, hospitals, healthcare systems, and specialty life sciences organizations. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Mass General Brigham | Academic health system / transplant care provider | Major Boston-area health system with transplant programs and likely local decision-maker relevance. | massgeneralbrigham.org | Transplant Director, Procurement Director, Service Line Administrator, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Massachusetts General Hospital | Hospital / transplant center | Leading academic hospital in the host city with direct relevance to transplant medicine. | massgeneral.org | Transplant Surgeon, Program Director, Supply Chain Manager, Clinical Research Director | Strong Market Fit, Attendance Not Confirmed |
| Brigham and Women’s Hospital | Hospital / transplant center | High-profile Boston academic medical institution relevant to transplant and specialty care purchasing. | brighamandwomens.org | Medical Director, Director of Transplantation, Strategic Sourcing Manager, Nurse Manager | Strong Market Fit, Attendance Not Confirmed |
| Beth Israel Deaconess Medical Center | Hospital / academic medical center | Relevant Boston transplant and clinical research institution. | bidmc.org | Transplant Program Director, Category Manager, Clinical Trials Director, VP Operations | Strong Market Fit, Attendance Not Confirmed |
| UCLA Health | Academic health system / transplant program | Major U.S. transplant center with likely national congress relevance. | uclahealth.org | Director of Transplant Services, Supply Chain Director, Clinical Innovation Director | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Health system / transplant center | Large transplant program and research organization with high buyer relevance. | mayoclinic.org | Transplant Chair, Director Procurement, Program Administrator, Research Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Health system / transplant center | Prominent transplant and specialty care provider relevant to high-complexity purchasing. | clevelandclinic.org | Department Chair, Procurement Manager, Clinical Director, Innovation Lead | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | Major institution for transplant research, specialty care, and evidence-based adoption. | hopkinsmedicine.org | Transplant Medical Director, Strategic Sourcing Director, Principal Investigator | Strong Market Fit, Attendance Not Confirmed |
| NYU Langone Health | Academic health system | Relevant national transplant and surgical innovation center. | nyulangone.org | Director of Transplantation, Supply Chain Leader, Clinical Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Cedars-Sinai | Hospital / transplant program | Active in advanced specialty care and relevant to transplant-related procurement. | cedars-sinai.org | Service Line Executive, Procurement Lead, Medical Director, Clinical Informatics Director | Strong Market Fit, Attendance Not Confirmed |
| UCSF Health | Academic health system / transplant center | Well-known transplant institution with strong clinical and research relevance. | ucsfhealth.org | Transplant Division Chief, Research Operations Director, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| United Network for Organ Sharing (UNOS) | National transplant network organization | Relevant to transplant operations, allocation systems, data, and ecosystem engagement. | unos.org | Program Director, Operations Director, IT Director, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Transplantation | Clinical Leadership | Director | Owns program strategy, clinical adoption, and vendor evaluation influence. |
| 2 | Transplant Surgeon / Surgical Director | Surgery | Director / Senior | Key influencer for devices, OR tools, preservation, and protocol-related solutions. |
| 3 | Transplant Medical Director | Medical Affairs / Clinical Operations | Director / Executive | Influences treatment pathways, diagnostics, and care management tools. |
| 4 | Supply Chain Director | Procurement / Supply Chain | Director | Responsible for sourcing, contracting, and standardization across hospital purchasing. |
| 5 | Strategic Sourcing Manager | Procurement | Manager | Directly involved in supplier selection and negotiation. |
| 6 | Transplant Program Administrator | Operations | Manager / Director | Controls operational implementation, budgeting, workflow, and vendor coordination. |
| 7 | Clinical Research Director | Research | Director | Important for studies, data tools, laboratory services, and trial partnerships. |
| 8 | Principal Investigator | Research / Clinical Trials | Senior / Director | High influence in evidence generation and adoption of research-based solutions. |
| 9 | Clinical Operations Director | Operations | Director | Relevant for implementation, staffing, process improvement, and quality outcomes. |
| 10 | Chief Medical Officer / Service Line Executive | Executive Leadership | Executive | Approves strategic investment and enterprise-level partnerships. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core transplant care buyer base | Hospital systems, transplant centers, specialty care operations |
| 2 | Medical Devices | Relevant to transplant surgery, preservation, and procedural technologies | Clinical equipment, surgical tools, monitoring devices |
| 3 | Pharmaceuticals | Strong fit for immunosuppression and transplant therapeutics | Clinical engagement, partnership, evidence generation |
| 4 | Biotechnology | Relevant to biomarkers, cell therapy, translational science | R&D partnerships and translational platform outreach |
| 5 | Research | Academic and clinical research institutions are central to ATC | Lab, trial, and data solution selling |
| 6 | Higher Education | Medical schools and universities host many transplant programs | Academic center procurement and investigator outreach |
| 7 | Information Technology & Services | Relevant for care workflow, data systems, patient monitoring, interoperability | Digital health and transplant operations technology |
| 8 | Computer Software | Applicable to registries, scheduling, analytics, remote care, and research platforms | Platform selling into transplant programs |
| 9 | Government Administration | Relevant where public health, transplant policy, and system oversight intersect | Policy, public program, and healthcare administration outreach |
| 10 | Nonprofit Organization Management | Includes donor advocacy and transplant-support organizations | Partnerships, education, patient support, donor engagement |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Several thousand attendees | Estimated | Historical scale of the ATC event series and market position as a major transplant congress | Attendance figure not publicly confirmed by the organizer for 2026. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official exhibitor prospectus / exhibit page should be checked when available | Likely includes pharma, biotech, diagnostics, devices, and healthcare service providers. |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer-registration breakout identified in public materials reviewed | ATC is a clinical/scientific congress, so buyer roles are embedded across hospitals and industry rather than separated as hosted buyers. |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda and faculty pages should be used for final verification | Expected to be substantial due to the congress format and scientific programming. |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official sponsor listings should be verified on the event website | Typically relevant for pharma, diagnostics, medtech, and specialty services. |
| Historical attendance | Major international congress with multi-thousand attendance profile | Historical / prior-year evidence | Event-series reputation and historical market positioning | Prior-year participation evidence. Not a confirmed attendee list for the current edition. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Transplant surgery | Better procedural outcomes, surgical efficiency, preservation support | Engage physician leaders and OR decision-makers | Surgical devices, preservation technology, procedure support tools |
| Immunosuppression and specialty therapeutics | Protocol optimization, rejection management, long-term outcomes | Medical affairs, investigator relationships, evidence-based engagement | Pharmaceuticals, biologics, companion services, adherence support |
| Diagnostics and biomarker monitoring | Earlier rejection detection, risk stratification, personalized care | Research-to-clinical adoption conversations | Molecular diagnostics, lab services, predictive analytics |
| Clinical research and trials | Study support, data capture, site collaboration, patient recruitment | Reach investigators and research operations teams | CRO services, EDC platforms, sample logistics, analytics |
| Hospital workflow and patient management | Care coordination, scheduling, documentation, follow-up compliance | Target administrators, coordinators, IT and operations leaders | Software, interoperability, patient communication, remote monitoring |
| Organ donation and program operations | Coordination, data exchange, education, stakeholder communication | Partner with donation networks and transplant operations leaders | Operational platforms, outreach tools, logistics support |
| Academic medicine and translational science | Funding leverage, platform validation, collaborative research | Scientific relationship-building with faculty and institutions | Research tools, grants support, data science, assay services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | ATC is a concentrated event for transplant-specific clinical and institutional stakeholders. |
| Decision-maker availability | High | Physician leaders, program directors, researchers, and hospital administrators are likely to be present. |
| Data collection potential | Medium | Good for targeted account mapping, but attendee data may be limited by medical conference privacy and access controls. |
| Apollo targeting potential | High | Hospitals, academic centers, biotech, diagnostics, and medtech companies can be filtered effectively in Apollo. |
| Geographic targeting potential | High | Boston local targeting plus national transplant-center targeting is practical and valuable. |
| Best outreach approach | High | Use account-based outreach tied to transplant outcomes, workflow, evidence, cost control, and institutional fit. |
| Overall lead quality | High | Best suited for specialized B2B healthcare, medtech, biotech, diagnostics, and transplant-adjacent solutions. |
| Best use case | High | ABM targeting, speaker/account mapping, exhibitor targeting, scientific networking, and transplant-center outreach. |
| Limitations / risks | Medium | Not ideal for broad consumer-health offers; current-year participant lists may not be publicly available; many conversations are clinically driven and require nuanced positioning. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Research; Higher Education; Information Technology & Services; Computer Software; Nonprofit Organization Management | Covers the main transplant ecosystem buyer groups. |
| Departments | Operations; Purchasing; Medical; Research; Information Technology; Program Management; Business Development | Targets both clinical influencers and institutional buyers. |
| Seniority | Director; VP; C-Level; Head; Manager; Partner; Owner where relevant for specialty vendors | Focuses on budget owners and adoption influencers. |
| Job titles | Director of Transplantation; Transplant Medical Director; Transplant Surgeon; Surgical Director; Supply Chain Director; Strategic Sourcing Manager; Transplant Program Administrator; Clinical Operations Director; Principal Investigator; Clinical Research Director; Service Line Director | Most aligned job functions for transplant-focused B2B selling. |
| Geography | United States; Massachusetts; Boston; Northeast U.S.; Canada if international outreach is relevant | Supports local-event targeting plus national transplant-center expansion. |
| Employee size | 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Best for hospitals, health systems, universities, and scaled life sciences companies. |
| Keywords | transplant, organ transplant, transplant center, nephrology, hepatology, immunology, donor, organ preservation, rejection monitoring, transplant surgery, academic medical center | Improves precision around transplant-related accounts and roles. |
| Technologies, if relevant | EHR, interoperability, remote monitoring, diagnostics platforms, clinical data tools | Useful when selling digital health, analytics, or connected clinical solutions. |
| Revenue range, if relevant | Mid-market to enterprise healthcare and life sciences organizations | Prioritizes accounts with purchasing power and research budgets. |
| Company type | Nonprofit hospitals; academic medical centers; health systems; public and private life sciences firms; research institutions | Matches the buyer mix most relevant to ATC. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| American Transplant Congress official website | Official event website | Primary event-series identity, congress branding, official program and future-edition verification when published | High |
| American Society of Transplantation (AST) | Official association website | Historical organizer relationship and association alignment for ATC | High |
| American Society of Transplant Surgeons (ASTS) | Official association website | Historical organizer relationship and surgical community connection | High |
| Boston Convention and Exhibition Center / Signature Boston | Official venue website | Venue identity and Boston convention infrastructure reference | High |
| User-provided event details | Provided input | 2026 dates, city, state, country, and venue name used in this report | Medium pending official event-page confirmation |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to American Transplant Congress 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.